发明名称 THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
摘要 <p>A therapeutic agent for ophthalmic diseases comprising Laennec (trade name) as an active ingredient. Laennec, the active ingredient, exhibits a therapeutic effect on a wide variety of ophthalmic diseases by increasing tears and the like and is highly safe even though it is an animal-derived component. Therefore, the therapeutic agent is applicable to the prevention and/or treatment of various types of ophthalmic diseases, particularly corneal disorders, dry eye, asthenopia, inflammatory ophthalmic diseases (e.g., meibomian gland dysfunction, Stevens-Johnson syndrome, Sjoegren syndrome, uveitis), ophthalmic diseases cause by active oxygen (e.g., cataract, glaucoma, age-related macular degeneration, optic disc atrophy).</p>
申请公布号 WO2006064672(A1) 申请公布日期 2006.06.22
申请号 WO2005JP22141 申请日期 2005.11.25
申请人 JAPAN BIOPRODUCTS IND. CO. LTD.;HIBINO, SAWAKO 发明人 HIBINO, SAWAKO
分类号 A61K35/50;A61K9/08;A61P27/14 主分类号 A61K35/50
代理机构 代理人
主权项
地址
您可能感兴趣的专利